CalciMedica Inc. (CALC)
2.07
-0.13 (-5.91%)
At close: Mar 04, 2025, 1:53 PM
CalciMedica Income Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 58K | 52K | 519K | 395K | 303K | 175K |
Gross Profit | -58K | -52K | -519K | -395K | -303K | -175K |
Operating Income | -21.88M | -36.18M | -35.95M | -29.83M | -37.5M | -28.57M |
Interest Income | n/a | 575K | 126K | 143K | 393K | 192K |
Pretax Income | -34.36M | -35.6M | -35.82M | -27.53M | -37.04M | -28.38M |
Net Income | -34.36M | -35.6M | -35.82M | -27.53M | -37.04M | -28.38M |
Selling & General & Admin | 9.46M | 19.1M | 17.04M | 8.87M | 6.92M | 5.6M |
Research & Development | 12.36M | 14.11M | 18.9M | 20.96M | 30.58M | 22.97M |
Other Expenses | n/a | 2.96M | n/a | 2.16M | 72K | n/a |
Operating Expenses | 21.82M | 33.22M | 35.95M | 29.83M | 37.5M | 28.57M |
Interest Expense | n/a | n/a | 126K | 143K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 21.88M | 33.22M | 35.95M | 29.83M | 37.5M | 28.57M |
Income Tax | -109.89K | 2.39M | -2M | -538K | -393K | 13.86K |
Shares Outstanding (Basic) | 4.49M | 1.53M | 1.51M | 472.75K | 1.03M | 857.28K |
Shares Outstanding (Diluted) | 4.49M | 1.53M | 1.51M | 472.75K | 1.03M | 857.28K |
EPS (Basic) | -7.65 | -23.2 | -23.66 | -58.24 | -35.85 | -33.1 |
EPS (Diluted) | -7.65 | -23.2 | -23.66 | -58.24 | -35.85 | -33.1 |
EBITDA | -34.19M | -7.64M | -35.3M | -27.14M | -36.73M | -28.2M |
Depreciation & Amortization | 58K | 52K | 519K | 395K | 303K | 175K |